- Home
- BLCO vs SFBS Comparison
BLCO vs SFBS Comparison
Compare BLCO & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- SFBS
- Stock Information
- Founded
- BLCO 1853
- SFBS 2005
- Country
- BLCO Canada
- SFBS United States
- Employees
- BLCO N/A
- SFBS N/A
- Industry
- BLCO Ophthalmic Goods
- SFBS Major Banks
- Sector
- BLCO Health Care
- SFBS Finance
- Exchange
- BLCO Nasdaq
- SFBS Nasdaq
- Market Cap
- BLCO 4.9B
- SFBS 4.6B
- IPO Year
- BLCO 2022
- SFBS 2014
- Fundamental
- Price
- BLCO $15.23
- SFBS $83.93
- Analyst Decision
- BLCO Hold
- SFBS Hold
- Analyst Count
- BLCO 11
- SFBS 1
- Target Price
- BLCO $15.80
- SFBS $90.00
- AVG Volume (30 Days)
- BLCO 492.5K
- SFBS 209.6K
- Earning Date
- BLCO 10-29-2025
- SFBS 10-20-2025
- Dividend Yield
- BLCO N/A
- SFBS 1.60%
- EPS Growth
- BLCO N/A
- SFBS 26.23
- EPS
- BLCO N/A
- SFBS 4.57
- Revenue
- BLCO $4,891,000,000.00
- SFBS $488,391,000.00
- Revenue This Year
- BLCO $8.27
- SFBS $25.86
- Revenue Next Year
- BLCO $5.73
- SFBS $14.42
- P/E Ratio
- BLCO N/A
- SFBS $18.32
- Revenue Growth
- BLCO 8.81
- SFBS 18.16
- 52 Week Low
- BLCO $10.45
- SFBS $66.48
- 52 Week High
- BLCO $21.69
- SFBS $101.37
- Technical
- Relative Strength Index (RSI)
- BLCO 59.83
- SFBS 47.34
- Support Level
- BLCO $15.00
- SFBS $83.31
- Resistance Level
- BLCO $15.50
- SFBS $89.62
- Average True Range (ATR)
- BLCO 0.34
- SFBS 1.71
- MACD
- BLCO 0.02
- SFBS -0.66
- Stochastic Oscillator
- BLCO 72.03
- SFBS 16.32
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.